Danaher DHR

HealthcareMarket cap $180B5 connections

Danaher is a science and technology company operating through Biotechnology (Cytiva bioprocessing), Life Sciences (Beckman Coulter diagnostics), and Environmental & Applied Solutions. Its Danaher Business System (DBS) - a continuous improvement culture borrowed from Toyota - consistently delivers 50%+ operating margins in its best businesses. The Cytiva spin-off is its most recent major portfolio move.

Explore Danaher on the interactive map Relationship timeline Find a path to another company

Customers 3

Companies Danaher sells to

PfizerHealthcare · $160BBiotech instruments
AmgenHealthcare · $160BLife science instruments
ModernaHealthcare · $45BManufacturing tools for vaccines

Partners 1

Strategic partnerships, joint products and alliances

Abbott LabsHealthcare · $200BCompeting diagnostics companies

Competitors 1

Companies it competes with

RevvityHealthcare · $11BLife science tools

Other Healthcare companies

Eli Lilly UnitedHealth Novo Nordisk Johnson & Johnson AbbVie Merck AstraZeneca Thermo Fisher Novartis Abbott Labs

Embed this on your site

Show Danaher's network in an article or report - it updates as our data does.

<iframe src="https://vexmap.com/embed.html?co=DHR" width="600" height="420" style="border:0;border-radius:12px;max-width:100%" title="Danaher on VexMap" loading="lazy"></iframe>

Preview

Relationships are compiled by VexMap from company filings, announcements and reporting, and last reviewed September 2026. Spotted something wrong? Tell us. Not investment advice.